FDA Warns of Dangers of Compounded Ketamine for Psychiatric Use

WEDNESDAY, Oct. 11, 2023 -- The U.S. Food and Drug Administration is warning consumers about risks of using compounded versions of the drug ketamine, often taken for psychiatric disorders.
Compounded products are not evaluated by the FDA for safety...